Cleveland Clinic Akron General
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, Cleveland Clinic Akron General sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
Cleveland Clinic Akron General: 5 sponsored US clinical trials, none currently recruiting.
Cleveland Clinic Akron General sponsors 5 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 3 completed. The most-studied condition in this pipeline is Epidermodysplasia Verruciformis, with 1 trials.
Upper-quartile sponsor footprint
Cleveland Clinic Akron General sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
5 total, page 1 of 1
Trial of Blood Flow Restriction Plus Physical Therapy vs. Physical Therapy Alone for Lateral Epicondylitis
NCT03978897
Food as Medicine: A Quasi-Randomized Control Trial of Healthy Foods for Chronic Disease Management
NCT05174078
Superficial Cervical Plexus Block for IJCL Pain Management
NCT05252832
Computational Simulation of Patellar Instability
NCT02998372
Evaluation of the Effectiveness of an Alcohol Based Hand Gel for the Reduction of Warts on the Hands
NCT00973856
Therapeutic Areas
How the Cleveland Clinic Akron General archive is shaped
5 indexed studies, none listed as recruiting (0% open); 3 completed (60%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Epidermodysplasia Verruciformis (1 trial), 8 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Cleveland Clinic Akron General: archived-pipeline peers nationwide
Peers matched on 5 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Cleveland Clinic Akron General sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 archived trials
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Cleveland Clinic Akron General page
5 registered trials is a research-attention snapshot, not an endorsement of Cleveland Clinic Akron General or any single study.
- None of Cleveland Clinic Akron General's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Epidermodysplasia Verruciformis is the condition Cleveland Clinic Akron General studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Epidermodysplasia Verruciformis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Cleveland Clinic Akron General pipeline card: 5 registered trials from official public datasets.Report a data error.